|
Forecast Period
|
2025-2029
|
|
Market Size (2023)
|
USD 450.63 Million
|
|
Market Size (2029)
|
USD 644.03 Million
|
|
CAGR (2024-2029)
|
6.09%
|
|
Fastest Growing Segment
|
Canine
|
|
Largest Market
|
West
|
Market Overview
United
States Veterinary Oncology Market was valued at USD 450.63 Million in 2023 and is expected to reach USD 644.03
Million by 2029 with a CAGR of 6.09% during the forecast period. The United
States veterinary oncology market is driven by several key factors. Increasing
pet ownership and a growing focus on pet health and well-being have heightened
demand for specialized veterinary care, including oncology services. Advances
in diagnostic and treatment technologies, such as improved imaging techniques
and novel cancer therapies, are enhancing the effectiveness of cancer care for
pets, leading to better outcomes and higher survival rates. Rising awareness
among pet owners about cancer prevention and early detection is encouraging
more individuals to seek veterinary oncology services. The aging pet population
further contributes to market growth, as older animals are more susceptible to
cancer. The expansion of veterinary practices and specialty clinics dedicated
to oncology is making these services more accessible, reinforcing the overall
growth of the United States Veterinary Oncology Market.
Key Market Drivers
Increasing Pet Ownership
The rise in pet ownership in the United States is a
significant driver of the United States Veterinary Oncology Market. With nearly
70% of American households now owning a pet, the sheer volume of animals
requiring medical care has increased dramatically. This surge in pet adoption
reflects broader societal trends where pets are increasingly regarded not just
as companions but as integral members of the family. As a result, pet owners are
more invested in their animals’ health and well-being, leading to a heightened
demand for veterinary services, particularly specialized oncology care. The
2024 APPA National Pet Owners Survey, referenced in APPA's State of the
Industry Report, reveals that 82 million households in the U.S. own a pet.
This evolving perspective has transformed how pet
owners approach healthcare for their animals. Owners are now more likely to
prioritize regular check-ups and screenings, particularly for conditions such
as cancer that can be life-threatening if not detected early. Preventive
healthcare has become a standard expectation, with many owners actively seeking
out veterinarians who provide comprehensive wellness programs that include
cancer screenings. This proactive approach not only helps in the early detection
of potential health issues but also contributes to better overall health
outcomes for pets. The increasing number of pets in the U.S. correlates with a
growing market for veterinary oncology products and services. As more
households adopt pets, the total pet population rises, which inevitably leads
to a higher incidence of age-related diseases, including cancer. Older pets,
who are more prone to various forms of malignancies, necessitate specialized
care, thereby expanding the market for veterinary oncology.
Rising Awareness of Pet Health
Growing awareness among pet owners regarding the
importance of pet health and wellness is a significant factor fueling the United
States Veterinary Oncology Market. In recent years, there has been a noticeable
shift in how pet owners perceive their pets’ health, driven largely by
educational campaigns and improved access to information through digital
platforms. These resources have empowered pet owners to better recognize the
early signs of health issues, including cancer, and to seek timely veterinary
care. As information about pet health becomes more readily available through
social media, blogs, and dedicated veterinary websites, pet owners are
increasingly educated about the various conditions that can affect their
animals. This surge in accessible information has created a more informed
public that understands not only the symptoms of cancer but also the importance
of regular check-ups and screenings for early detection. Many owners now
recognize that early intervention can lead to significantly better outcomes for
their pets, including increased survival rates and improved quality of life.
This heightened awareness has led to a substantial
increase in routine veterinary visits. Pet owners who may have previously only
sought care in emergencies are now scheduling regular check-ups, understanding
that preventative care is vital. These visits often include discussions about
cancer risks, particularly in older pets or breeds predisposed to certain types
of cancer. As a result, veterinarians are better positioned to detect potential
issues early, facilitating prompt intervention that can dramatically alter the
course of treatment. This increased focus on health awareness encourages pet
owners to consider advanced treatment options when their pets are diagnosed
with cancer. Once faced with a cancer diagnosis, informed pet owners are more
likely to explore all available avenues, including specialized veterinary
oncology services. They are increasingly willing to invest in advanced
diagnostic tools and therapies that were previously overlooked or considered
too expensive. This willingness not only benefits the pets but also propels the
growth of the United States Veterinary Oncology Market as a whole.
Expansion of Veterinary Practices and Specialty
Clinics
The growth of veterinary practices and specialty
clinics dedicated to oncology is significantly impacting the United States
Veterinary Oncology Market. As awareness of pet health issues rises and the
demand for specialized care increases, veterinary professionals are
increasingly pursuing training in oncology. This trend has led to a
proliferation of specialty clinics that focus exclusively on cancer treatment
for pets, providing a much-needed resource for pet owners seeking advanced care
options. These specialty clinics are equipped with advanced diagnostic tools
and treatment modalities that general veterinary practices may not have the
capability to offer. For example, many oncology clinics utilize cutting-edge
imaging technologies, such as MRI and CT scans, to accurately diagnose tumors
and determine the best course of treatment. They often provide access to
specialized therapies, including chemotherapy, immunotherapy, and targeted
therapies, that are essential for effectively managing cancer in pets. The
availability of such advanced resources not only improves diagnostic accuracy
and treatment efficacy but also enhances the overall quality of care that pets
receive. In December 2023, Online pet supply retailer Chewy announced it
plans to open veterinary clinics in 2024. The company will launch several
practices under the brand name “Chewy Vet Care,” with the first location set to
open in South Florida early next year. These clinics will provide a range of
services, including routine appointments, urgent care, and surgical procedures.
Current listings on the Chewy Vet Care website indicate job openings for
veterinarians, veterinary technicians, and support staff in Plantation,
Florida—where the company is based—and in Denver. The clinics will utilize
Chewy’s online platform, which integrates with the Chewy Vet Care website and
third-party partner practices.
The presence of specialized clinics significantly
enhances accessibility for pet owners. In the past, owners may have had to
travel long distances to seek specialized oncology care, which could deter them
from pursuing the treatment their pets needed. However, the rise of local
specialty clinics means that many pet owners can access targeted oncology
services within a reasonable distance from their homes. This increased
accessibility encourages more pet owners to seek out the care their animals
need, ultimately contributing to earlier diagnoses and better treatment
outcomes. As the number of specialty clinics expands, competition within the United
States Veterinary Oncology Market is likely to increase. This heightened
competition can lead to improvements in service quality, as clinics strive to
differentiate themselves by offering the best possible care. Innovations may
emerge in treatment protocols, customer service, and overall patient
experience. Clinics may also collaborate on research and share best practices,
further enhancing the quality of care provided across the board.
Government and Nonprofit Initiatives
Government and nonprofit organizations play a
crucial role in promoting veterinary oncology through funding, education, and
awareness initiatives. Grants and funding for research in veterinary medicine
contribute to advancements in treatment and care for pets with cancer. Educational
campaigns aimed at both veterinarians and pet owners help raise awareness about
the importance of early detection and treatment of cancer in pets.
Organizations dedicated to veterinary oncology often provide resources and
support for pet owners facing cancer diagnoses, fostering a community focused
on improving pet health outcomes. These initiatives not only enhance the
visibility of veterinary oncology but also encourage a culture of proactive pet
healthcare, ultimately driving the growth of the market. By raising awareness
and providing support, these organizations help ensure that pets receive the
timely and effective care they need, reinforcing the overall demand for
veterinary oncology services.
.png)
Download Free Sample Report
Key Market Challenges
High Cost of Treatments
One of the most significant challenges in the United
States Veterinary Oncology Market is the high cost of treatments. Advanced
therapies, including chemotherapy, radiation, and surgical interventions, can
be prohibitively expensive for many pet owners. The financial burden can deter
them from seeking necessary care for their pets, particularly when they face
significant costs associated with diagnostic procedures and ongoing treatments.
This financial barrier is further compounded by the fact that many pet
insurance plans do not cover specialized oncology services or have limitations
on coverage. As a result, pet owners often find themselves in a difficult
position, having to weigh the quality of care against their financial
situation. The perception that veterinary oncology is too expensive can lead to
delays in treatment or, in some cases, the decision to forego care altogether.
This not only impacts the health outcomes for pets but also contributes to the
overall stagnation of the United States Veterinary Oncology Market, as
potential clients opt out of specialized care. Addressing these cost challenges
requires a multi-faceted approach, including more affordable treatment options,
better insurance coverage for oncology services, and increased public awareness
about the importance of pet health investments.
Limited Research Funding
Limited research funding is another major challenge
hindering the advancement of veterinary oncology. While there has been an
increase in interest in this field, funding for research studies, clinical
trials, and innovative treatment development often falls short. This lack of
financial support can limit the scope and scale of research initiatives,
slowing the discovery of new therapies and treatment protocols. Veterinary
oncology does not attract the same level of investment as human oncology,
leading to fewer resources for studying cancer biology in pets and exploring
novel treatment options. The disparity in funding can create a cycle where less
research leads to fewer advancements, which in turn results in reduced interest
from investors and funding bodies. To overcome this challenge, there needs to
be greater collaboration between veterinary institutions, pharmaceutical
companies, and research organizations to secure funding and drive forward
initiatives that focus on improving cancer care for pets. Increased funding not
only supports research but also fosters innovation, ultimately benefiting the United
States Veterinary Oncology Market and the pets it serves.
Key Market Trends
Advances in Diagnostic and Treatment Technologies
Technological advancements in veterinary medicine
have significantly transformed the landscape of veterinary oncology,
revolutionizing how veterinarians diagnose and treat cancer in pets. One of the
most impactful innovations is the development of advanced imaging techniques,
such as MRI, CT scans, and ultrasound. These tools enable veterinarians to
visualize internal structures with remarkable clarity, allowing for more
accurate and early-stage diagnoses of cancer. For instance, MRI and CT scans
can reveal the size, location, and extent of tumors, while ultrasound helps
assess the involvement of surrounding tissues and organs. This early detection
is crucial because it often allows for timely intervention, improving the
chances of successful treatment and better overall outcomes for pets.
In addition to enhanced diagnostic capabilities,
breakthroughs in treatment modalities have profoundly influenced veterinary
oncology. Targeted therapies, for example, are designed to specifically attack
cancer cells while sparing healthy tissues, leading to fewer side effects
compared to traditional chemotherapy. Immunotherapy, which harnesses the body’s
immune system to fight cancer, has also gained traction in veterinary medicine,
providing new hope for pets facing malignancies that may not respond to conventional
treatments. These innovative therapies not only improve the effectiveness of
treatment but also enhance the quality of life for pets undergoing cancer care.
Surgical techniques have also seen significant advancements, allowing for more
precise and less invasive procedures. Minimally invasive surgical techniques,
such as laparoscopic surgery, enable veterinarians to perform complex tumor
removals with smaller incisions, resulting in reduced recovery times and less
pain for the animal. As a result, pets can return to their normal activities
more quickly, which is a considerable benefit for both the animals and their
owners.
Innovative Research and Clinical Trials
Ongoing research and clinical trials in veterinary
oncology are paving the way for new treatment options and therapies,
significantly driving market growth. The focus on understanding cancer biology
in pets has gained momentum in recent years, as veterinary professionals and
researchers work collaboratively to uncover the complexities of how different
types of cancer manifest and progress in animals. This research is essential,
as it lays the groundwork for the development of innovative therapies tailored
specifically to treat various cancers in pets. Clinical trials play a crucial
role in this landscape, offering pet owners the opportunity to access
cutting-edge treatments that may not yet be widely available in standard
veterinary practices. These trials often involve new drugs, treatment
protocols, and combination therapies that are at the forefront of veterinary
oncology. By participating in clinical trials, pet owners can provide their
animals with access to potentially life-saving therapies while also
contributing to the advancement of veterinary medicine. This dual benefit makes
participation in clinical trials an attractive option for many pet owners,
particularly those facing challenging diagnoses. In November 2023, a study
from the University of Colorado Cancer Center reported on a new clinical trial
at Colorado State University that is investigating CAR T-cell therapy for dogs
with metastatic osteosarcoma. This initiative highlights the rising demand for
advanced cancer treatments in canine oncology. The innovative approach seeks to
overcome the limitations of current therapies, underscoring the expanding
market for specialized cancer care in dogs. This growth is largely fueled by
the increasing prevalence of cancer in canines and the pressing need for
state-of-the-art treatment options.
The advancements emerging from these trials not
only improve treatment outcomes for pets but also foster a sense of hope and
optimism among pet owners. Many owners are eager to explore the latest options
for their animals, especially when traditional treatments may have failed or
when their pets are diagnosed with aggressive forms of cancer. The possibility
of accessing novel therapies can be a game changer for families who are
navigating the emotional and financial challenges of a cancer diagnosis. The
visibility of successful outcomes from clinical trials enhances awareness and
interest in veterinary oncology, encouraging more pet owners to consider
specialized care.
Segmental Insights
Animal Type Insights
Based on the Animal Type, Canines
are currently the dominant species driving demand for cancer treatment and
services in the United States Veterinary Oncology Market. This trend can be
attributed to several factors that contribute to the increased susceptibility
of dogs to cancer compared to other pets, such as cats and horses.
Statistically, it is estimated that approximately one in four dogs will develop
cancer in their lifetime, a rate that is significantly higher than that
observed in felines, where the incidence is closer to one in five. This
heightened prevalence of cancer in dogs has led to a greater awareness and
focus on canine oncology, prompting both pet owners and veterinary
professionals to prioritize cancer screenings, early detection, and the
exploration of advanced treatment options.
One of the key factors
influencing the higher cancer rates in dogs is their genetic diversity and the
effects of breeding practices. Certain breeds, especially purebreds, are
predisposed to specific types of cancers due to hereditary factors. Breeds such
as Golden Retrievers, Boxers, and Rottweilers have particularly high cancer
rates, which has raised concerns among breeders, veterinarians, and pet owners
alike. This genetic predisposition has led to increased research efforts aimed
at understanding the underlying mechanisms of cancer in these breeds, resulting
in a more tailored approach to prevention and treatment. The longevity of pet
dogs has increased due to advancements in veterinary care, nutrition, and
overall pet health awareness. As dogs live longer, they are more likely to
develop age-related diseases, including various forms of cancer. This shift has
prompted pet owners to invest more in their dogs' healthcare, including regular
check-ups, preventive screenings, and specialized cancer care. The awareness
that early detection often leads to more effective treatment outcomes has made
routine veterinary visits an essential part of responsible pet ownership.
Therapy Insights
Based on the Therapy, chemotherapy
currently stand out as the dominated treatment modality for managing cancer in
pets, particularly dogs. This prominence is attributed to several factors,
including the broad range of cancers it can treat, its established protocols,
and its accessibility for both veterinarians and pet owners. Chemotherapy
involves the use of potent drugs designed to target and kill rapidly dividing
cancer cells, and it is often utilized in various treatment regimens for
conditions such as lymphoma, mast cell tumors, and osteosarcoma, among others.
One key reason for
chemotherapy’s dominance is its effectiveness in treating specific types of
cancer that are prevalent in canines. Lymphoma, for instance, is one of the
most common cancers diagnosed in dogs and responds well to chemotherapy, often
resulting in significant remission periods. The established protocols and
dosages for various chemotherapy drugs have been well-documented in veterinary
literature, allowing veterinarians to confidently administer treatment based on
best practices. This level of knowledge contributes to the widespread
acceptance and application of chemotherapy in veterinary oncology. Accessibility
is another critical factor influencing the prominence of chemotherapy. Many
general veterinary practices offer chemotherapy as part of their services,
making it more readily available to pet owners compared to other modalities
like radiation therapy, which often requires specialized facilities. This
convenience encourages pet owners to pursue chemotherapy when faced with a
cancer diagnosis, as they can often receive treatment in familiar settings. The
relative affordability of certain chemotherapy drugs, especially when compared
to advanced surgical interventions or immunotherapy, makes it a viable option
for many pet owners who may be navigating the financial burdens associated with
cancer treatment.
.png)
Download Free Sample Report
Regional Insights
In the United States veterinary oncology market,
the West region is currently the dominant area, driving demand for specialized
cancer treatments for pets. Several factors contribute to this trend, including
a higher concentration of veterinary oncology clinics, greater access to
advanced treatment technologies, and a more significant awareness of pet health
and wellness among pet owners in the West. One of the key reasons for the
West's prominence in the United States Veterinary Oncology Market is the
region's robust infrastructure for veterinary care. States like California and
Washington host numerous specialty veterinary clinics and referral centers
dedicated to oncology. These facilities are often equipped with
state-of-the-art technologies, such as advanced imaging equipment and
cutting-edge treatment modalities, allowing for more effective diagnosis and
management of pet cancers. The availability of specialized services ensures
that pet owners have greater access to high-quality care, significantly
influencing their decisions regarding treatment options.
The cultural attitude toward pet ownership in the
West tends to prioritize animal health and wellness. Many pet owners view their
animals as family members, leading to increased spending on veterinary care,
including specialized oncology services. This heightened focus on pet health
results in more proactive measures, such as regular veterinary check-ups and
screenings for early signs of cancer. Consequently, the demand for veterinary
oncology services is amplified, driving growth in the market. The West region
also benefits from a strong network of veterinary professionals committed to
ongoing education and collaboration in the field of oncology. Many
veterinarians in this region actively participate in continuing education
programs, conferences, and research initiatives that focus on advancements in
cancer treatment for pets. This dedication to staying current with the latest
developments in veterinary oncology ensures that practitioners can offer the
best possible care to their patients, further solidifying the West’s position
as a leader in this field.
Recent Developments
- In March 2024, ELIAS Animal
Health, a company focused on cancer therapeutics for companion animals,
recently announced that the United States Department of Agriculture (USDA) has
determined their new technology for treating osteosarcoma in dogs to have a
reasonable expectation of efficacy. This decision paves the way for the
licensure of this innovative treatment option, designed to combat a lethal and
aggressive cancer in canine patients.
- In April 2023, Torigen
Pharmaceuticals announced a partnership with Veterinary Management Groups (VMG)
to offer over 2,000 VMG member clinics access to Torigen's experimental
autologous cancer immunotherapies. This collaboration aims to improve the availability
of advanced cancer treatments for companion animals by combining Torigen's
innovative solutions with VMG's extensive network, thereby expanding treatment
options for pet owners throughout the U.S.
- In October 2023, Washington
State University has successfully installed a new linear accelerator at its
Veterinary Teaching Hospital, which will enable advanced radiation therapy and
life-saving treatments for animal cancer patients. This linear accelerator, or
LINAC, is engineered to safely and precisely target intense energy beams to
destroy cancer cells while minimizing damage to surrounding healthy tissue. The
oncology team utilizes this technology for treating various cancers, including
mast cell tumors, soft tissue sarcomas, and several oral, nasal, and brain
tumors. The teaching hospital is among only a few veterinary facilities in the
Northwest equipped with this critical technology.
Key Market Players
- Elanco Animal Health Incorporated
- Boehringer Ingelheim Animal Health USA Inc.
- Zoetis Inc
- Virbac Corporation
- Merck & Co., Inc.
- Ardent Animal Health, LLC
- Arizona Veterinary Oncology
- Varian Medical Systems, Inc.
- PetVet Care Centers
- Las Vegas Veterinary Specialty Center
|
By Animal Type
|
By Therapy
|
By Cancer Type
|
By Region
|
|
|
- Radiotherapy
- Surgery
- Chemotherapy
- Immunotherapy
- Other Therapies
|
- Skin Cancers
- Lymphomas
- Sarcomas
- Others
|
- North-East
- Mid-West
- West
- South
|
Report Scope:
In this report, the United States Veterinary
Oncology Market has been segmented into the following categories, in addition
to the industry trends which have also been detailed below:
- United States Veterinary
Oncology Market, By
Animal Type:
o Canine
o Feline
o Equine
- United States Veterinary
Oncology Market, By
Therapy:
o Radiotherapy
o Surgery
o Chemotherapy
o Immunotherapy
o Other Therapies
- United States Veterinary
Oncology Market, By
Cancer Type:
o Skin Cancers
o Lymphomas
o Sarcomas
o Others
- United States Veterinary
Oncology Market, By Region:
o North-East
o Mid-West
o West
o South
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents
in the United States Veterinary Oncology Market.
Available Customizations:
United States Veterinary Oncology Market report
with the given market data, TechSci Research offers customizations according
to a company's specific needs. The following customization options are
available for the report:
Company Information
- Detailed analysis and
profiling of additional market players (up to five).
United States Veterinary Oncology Market is an
upcoming report to be released soon. If you wish an early delivery of this
report or want to confirm the date of release, please contact us at [email protected]